James Poock, MD
Family Medicine · Waterloo, IANPI 1740260074
Payments from drug & device makers
Across 396 payments — averaging $3698.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$466K
- CSL Behring$376K
- Amgen$255K
- Radius Health, Inc.$145K
- AstraZeneca$77K
- Regeneron$67K
- plus $80K from 22 others
Across 3 payments — averaging $4406.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$13K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 2 | $465,864 |
| CSL Behring | 91 | $375,833 |
| Amgen | 39 | $254,708 |
| Radius Health, Inc. | 78 | $144,508 |
| AstraZeneca(2 entities) | 22 | $77,181 |
| Regeneron | 22 | $66,502 |
| Sanofi US Services Inc. | 7 | $45,904 |
| Esperion Therapeutics, Inc. | 56 | $22,139 |
| Novartis | 4 | $9,599 |
| E.r. Squibb & Sons, L.L.C. | 3 | $1,279 |
| Pfizer | 17 | $270 |
| AbbVie(2 entities) | 9 | $141 |
| Novo Nordisk | 9 | $137 |
| Boehringer Ingelheim | 5 | $93 |
| Kyowa Kirin, Inc. | 4 | $89 |
| Lilly USA, LLC | 6 | $83 |
| Phathom Pharmaceuticals, Inc. | 3 | $63 |
| Ultragenyx Pharmaceutical Inc. | 4 | $54 |
| Abbott | 2 | $41 |
| GSK | 2 | $40 |
| Astellas Pharma US Inc | 3 | $39 |
| Almatica Pharma LLC | 2 | $32 |
| Lexicon Pharmaceuticals, Inc. | 1 | $30 |
| Alvogen Inc | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
How this compares
$1,464,713 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Waterloo
- Nicholas GoetschWaterloo$4.1M
- Garold MoyerWaterloo$53K
- Matthew SmithWaterloo$25K
- Gregory HarterWaterloo$14K
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.